Juguilon, Elsa L.
HRN: 20-05-95 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2024
CO-AMOXICLAV 625MG (TAB)
09/15/2024
09/21/2024
PO
625 Mg
BID
Sp Nsvd With Rmle
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes